Abstract | Background: Methods: In this prospective study, we consecutively enrolled 3,306 post-MI patients to assess the recurrent MACE. The predictive values of NT-proBNP and hs-CRP alone and together were assessed by multivariable Cox regression using hazard ratios (HR) and 95% confidence intervals (CI). Results: During the 4-year follow-up period, 335 patients developed recurrent MACE. Multivariate Cox regression analysis showed a significant correlation between NT-proBNP levels and MACE (HR: 2.99, 95%CI: 2.06-4.36, p < 0.001), hard endpoints (HR: 5.44, 95%CI: 2.99-9.90, p < 0.001), cardiac mortality (HR: 5.92, 95%CI: 2.34-14.96, p < 0.001) and all-cause mortality (HR: 5.03, 95%CI: 2.51-10.09, p < 0.001). However, hs-CRP was not an independent predictor after adjusting for NT-proBNP. When patients were divided into six groups by using tertiles values of NT-proBNP and median values of hsCRP, patients with high NT-proBNP/ hs-CRP values were 3.27 times more likely to experience MACE than patients with low NT-proBNP/ hs-CRP values. The addition of NT-proBNP and hs-CRP to a prognostic model revealed a significant improvement in C-statistic, net reclassification, and integrated discrimination. Conclusions: Increased NT-proBNP levels were associated with long-term worse outcomes and the combination of NT-proBNP and hs-CRP has an incremental value in the further risk stratification of post-MI patients.
|
Authors | Ye-Xuan Cao, Sha Li, Hui-Hui Liu, Meng Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Ke-Fei Dou, Jian-Jun Li |
Journal | Frontiers in cardiovascular medicine
(Front Cardiovasc Med)
Vol. 9
Pg. 797297
( 2022)
ISSN: 2297-055X [Print] Switzerland |
PMID | 35282356
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Cao, Li, Liu, Zhang, Guo, Wu, Zhu, Dong, Sun, Dou and Li. |